Difference between revisions of "Part:BBa K5374013"
Francisgrace (Talk | contribs) |
Francisgrace (Talk | contribs) |
||
Line 36: | Line 36: | ||
</ul> | </ul> | ||
<p>Overall, the majority of CBDs retained sufficient EGFP activity, which confirms that they can be used in further experiments for controlled release without significantly impairing the functionality of the fusion proteins. These results support the selection of CBDs that balance collagen binding with maintaining protein bioactivity.</p> | <p>Overall, the majority of CBDs retained sufficient EGFP activity, which confirms that they can be used in further experiments for controlled release without significantly impairing the functionality of the fusion proteins. These results support the selection of CBDs that balance collagen binding with maintaining protein bioactivity.</p> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</html> | </html> | ||
Latest revision as of 13:35, 22 September 2024
DDR-EGFP (Discoidin Domain Receptor). A receptor tyrosine kinase activated by collagen, fused with E
The Discoidin Domain Receptor (DDR) is involved in collagen binding and ECM remodeling. Fusion with EGFP allows evaluation of DDR’s impact on protein bioactivity and provides a screening system for DDR as a potential tag for controlling collagen-based protein release.
The fluorescence data were obtained by expressing various EGFP fusion proteins in E. coli, diluting each culture to an equal cell density. Fluorescence intensity was measured for each group, and the fluorescence ratio relative to EGFP (used as a standard) was calculated. The figure shows these normalized fluorescence values for each fusion protein.
Figure 1.1 The fluorescence activity of each fusion protein
The fluorescence activity of each fusion protein was tested to evaluate whether the CBDs affected EGFP activity. The relative fluorescence values of the eight CBD-EGFP fusion proteins were measured to assess the impact of the collagen-binding domains (CBDs) on EGFP activity. As shown in the graph:
- SPARC/OD-EGFP, CBD MMPs-EGFP, DB-EGFP, VWF-A Domain-EGFP, and FTD-EGFP exhibited fluorescence values close to or higher than that of the control EGFP, indicating that these CBDs did not significantly affect the bioactivity of EGFP.
- DDR-EGFP, AGR-EGFP and COMP-EGFP showed slightly lower fluorescence values, suggesting some impact on EGFP activity, but still maintaining measurable fluorescence.
Overall, the majority of CBDs retained sufficient EGFP activity, which confirms that they can be used in further experiments for controlled release without significantly impairing the functionality of the fusion proteins. These results support the selection of CBDs that balance collagen binding with maintaining protein bioactivity.
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal EcoRI site found at 253
Illegal EcoRI site found at 337
Illegal EcoRI site found at 820
Illegal PstI site found at 259 - 12INCOMPATIBLE WITH RFC[12]Illegal EcoRI site found at 253
Illegal EcoRI site found at 337
Illegal EcoRI site found at 820
Illegal NheI site found at 835
Illegal PstI site found at 259 - 21INCOMPATIBLE WITH RFC[21]Illegal EcoRI site found at 253
Illegal EcoRI site found at 337
Illegal EcoRI site found at 820
Illegal BglII site found at 459 - 23INCOMPATIBLE WITH RFC[23]Illegal EcoRI site found at 253
Illegal EcoRI site found at 337
Illegal EcoRI site found at 820
Illegal PstI site found at 259 - 25INCOMPATIBLE WITH RFC[25]Illegal EcoRI site found at 253
Illegal EcoRI site found at 337
Illegal EcoRI site found at 820
Illegal PstI site found at 259
Illegal NgoMIV site found at 588 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 1478